Skip to content

Alterations in gut microbiome in PCOS

Comparison of gut microbiome in patients with PCOS versus Controls: A Cross-sectional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092976
Enrollment
120
Registered
2025-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Blood sample: Blood sample will be collected from each subject at two time points. A fasting blood sample and a post 75 g OGTT (2h hour) blood sample. Intervention2: Nil: Nil

Sponsors

Endocrinology Department Development Fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CASES: ANY FEMALE FULFILLING ROTTERDAM CRITERIA FOR DIAGNOSIS OF PCOS CONTROLS: ANY FEMALE WITH REGULAR MENSTRUAL CYCLES

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA: 1.Hyperprolactinemia 2.Thyroid dysfunction 3.Cushing s syndrome and exogenous steroid therapy 4.Androgen-secreting tumours 5.Non classic congenital adrenal hyperplasia 6.Diabetes Mellitus 7.Patients on treatment for insulin resistance 8.Patients on treatment with oral contraceptive pills 9.Pregnant and lactating females 10.Patients who took antibiotics/ prebiotics in previous 1 month 11.Gastrointestinal disease (Ulcerative Colitis, Crohn s disease, Malignancy, Colitis, Enteritis) 12.Patients with either acute or chronic systemic illnesses

Design outcomes

Primary

MeasureTime frame
To compare alpha diversity of gut microbiome between treatment naive PCOS patients with age and BMI matched controlsTimepoint: at the completion of study

Secondary

MeasureTime frame
To compare beta diversity indices of gut microbiome between treatment naive PCOS patients with age & BMI matched controls 2. To study correlation between hormonal & metabolic markers & microbial diversity indices. 3. To study & compare relative abundances of bacteria between treatment naive PCOS patients with age & BMI matched controls 4. To study correlation between clinical parameters & microbial diversity indices.Timepoint: At the completion of the study

Countries

India

Contacts

Public ContactDr. Nikhil Bhagwat

TNMC AND NAIR HOSPITAL

ashmika18jain@gmail.com9820238399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026